Hmox1 mRNA expression levels of tumor-infiltrating myeloid cells were enhanced in the PTX-treated 4T1 breast cancer group relative to an untreated 4T1 breast cancer group (Figure 4B). The gene discussed is HMOX1; the disease is breast cancer.